Lupus is a chronic autoimmune disease in which the immune system mistakenly attacks healthy tissues throughout the body. Instead of limiting its defenses to viruses and bacteria, the immune system produces antibodies that target the body’s own cells, causing inflammation and damage in joints, skin, kidneys, the heart, lungs, and brain. About 204,000 people in the United States have the most common form, systemic lupus erythematosus (SLE), and 9 out of 10 of them are women.
How Lupus Works Inside the Body
In a healthy immune system, antibodies lock onto foreign invaders and flag them for destruction. In lupus, certain immune cells go wrong and begin producing autoantibodies that instead target materials inside your own cells, particularly DNA and the proteins that bind to it. These autoantibodies latch onto their targets and form clumps called immune complexes, which settle into tissues and trigger inflammation.
That inflammation is amplified by a signaling molecule called type I interferon, which normally helps fight viral infections. In lupus, interferon stays elevated and acts like a constant alarm signal, pushing the immune system into overdrive. It drives more immune cells to mature into autoantibody-producing factories, which creates a self-reinforcing cycle: more autoantibodies lead to more immune complexes, which trigger more interferon, which produces still more autoantibodies. This feedback loop is a core reason lupus is so difficult to shut down once it starts.
Types of Lupus
Systemic lupus erythematosus is the most common and most serious form. “Systemic” means it can affect virtually any organ, and its severity ranges from mild joint pain and skin rashes to life-threatening kidney or heart inflammation. When people say “lupus” without further qualification, they almost always mean SLE.
Cutaneous lupus is limited to the skin. It can appear as round, scaly patches (discoid lupus) or as wider, red areas that develop after sun exposure. Some people with cutaneous lupus never develop systemic disease, while others eventually do.
Drug-induced lupus is triggered by a reaction to certain medications. It generally produces milder symptoms than SLE and typically resolves once the offending drug is stopped. Neonatal lupus is rare and affects newborns of mothers who carry specific antibodies. It usually clears within a few months after birth.
Common Symptoms
Lupus symptoms vary widely from person to person, which is one reason diagnosis can take years. The most frequently reported symptoms include:
- Persistent fatigue that doesn’t improve with rest
- Joint pain, stiffness, and swelling, often with at least 30 minutes of morning stiffness
- A butterfly-shaped rash across the cheeks and bridge of the nose (many but not all people with lupus develop this)
- Skin sensitivity to sunlight, with rashes worsening after UV exposure
- Unexplained fevers
- Fingers and toes turning white or blue in cold temperatures or during stress
- Chest pain and shortness of breath
- Headaches, confusion, and memory problems
Symptoms tend to come and go in cycles called flares and remissions. During a flare, inflammation ramps up and symptoms worsen. During remission, you may feel nearly normal.
What Triggers Flares
Sunlight is one of the most powerful triggers. In up to 80 percent of people with lupus, UV exposure can set off both skin inflammation and systemic flares. Research at Dartmouth’s Geisel School of Medicine found that even a single exposure to UV light can stimulate inflammatory and injury processes in the kidneys, suggesting the skin acts as a launchpad for inflammation that spreads internally. Wearing broad-spectrum sunscreen and protective clothing is one of the simplest ways to reduce flare frequency.
Other common triggers include infections, emotional or physical stress, sleep deprivation, and certain medications. Hormonal shifts also play a role, which partially explains why lupus is so much more common in women of childbearing age.
Who Gets Lupus
Women between the ages of 15 and 44 face the highest risk. Of the estimated 204,000 Americans with SLE, roughly 184,000 are female and 20,000 are male. Race matters too: Black and American Indian/Alaska Native women are two to three times more likely than White women to develop lupus. Hispanic and Asian populations are also affected at higher rates than White populations. The reasons involve a combination of genetic susceptibility and socioeconomic factors that influence access to care and disease outcomes.
How Lupus Is Diagnosed
There is no single test that confirms lupus. Diagnosis relies on a combination of blood work, symptom history, and sometimes tissue biopsies. The process typically starts with a blood test for antinuclear antibodies (ANA). A positive ANA result doesn’t mean you have lupus on its own, since many healthy people test positive, but a negative result makes lupus very unlikely.
Rheumatologists use a classification system that assigns points across clinical categories: skin rashes, joint involvement, kidney problems, blood cell abnormalities, neurological symptoms, and several immune markers. A score of 10 or more, with at least one clinical symptom present, supports a diagnosis of SLE. Kidney involvement, for example, carries the heaviest weight in the scoring system because it signals serious disease. More specific antibody tests, such as those targeting double-stranded DNA, help distinguish lupus from other autoimmune conditions.
Kidney Involvement
Lupus nephritis, or kidney inflammation caused by lupus, affects approximately 40 percent of people with SLE. The kidneys are especially vulnerable because immune complexes circulating in the blood tend to accumulate in the tiny filtering units of the kidneys, where they provoke inflammation and scarring.
Early kidney damage often produces no noticeable symptoms, which is why routine monitoring matters. Your doctor will check blood pressure, urine protein levels, and complement proteins in the blood at regular intervals. Persistent protein in the urine (above 0.5 grams per day) or the presence of red blood cells in urine sediment are key warning signs. Catching kidney involvement early dramatically improves outcomes, since untreated lupus nephritis can progress to kidney failure.
Treatment and Management
Lupus treatment centers on controlling inflammation and preventing flares. An antimalarial medication, hydroxychloroquine, is the backbone of therapy for most people with lupus. It reduces flare frequency, protects against organ damage over time, and is generally well tolerated as a daily pill taken once or twice a day. Most rheumatologists recommend that nearly every lupus patient stay on it long-term.
Beyond hydroxychloroquine, treatment is tailored to severity. Mild disease involving joints and skin may need only anti-inflammatory medications and sun protection. Moderate to severe disease, particularly when the kidneys, heart, or brain are involved, often requires stronger immune-suppressing medications. Biologic therapies that target specific parts of the immune system, such as the B cells responsible for producing autoantibodies, are available for cases that don’t respond to standard treatment.
Living with lupus also means managing day-to-day triggers. Consistent sun protection, adequate sleep, stress management, and staying current on vaccinations (since infections can spark flares) all play a role in keeping the disease quiet.
Lupus and Pregnancy
Pregnancy is possible with lupus, but it carries increased risks including preeclampsia, blood clotting complications, and flares. The safest time to conceive is during a period of stable remission, ideally after at least six months of quiet disease. Certain lupus medications must be stopped well before conception because they can harm a developing baby, while hydroxychloroquine is generally continued throughout pregnancy because stopping it raises the risk of a flare.
Low-dose aspirin starting at 12 weeks of pregnancy helps reduce the risk of preeclampsia in women with lupus. Pregnancies are typically managed jointly by a rheumatologist and a maternal-fetal medicine specialist, with more frequent monitoring than a standard pregnancy.
Survival and Long-Term Outlook
The outlook for people with lupus has improved dramatically. In the 1960s, the 10-year survival rate was around 58 percent. By 2020, it had climbed to roughly 90 percent. The 20-year survival rate similarly rose from about 59 percent in the 1990s to 84 percent by 2020. These gains reflect earlier diagnosis, better medications, and improved management of complications like kidney disease.
Lupus remains a serious, lifelong condition that requires ongoing medical care. But most people with lupus today live full lives, especially when the disease is caught early and managed proactively.